Cost-effectiveness of switching antiretroviral therapy to British HIV Association recommended regimens

被引：0
|
作者：
Ireland, Aidan [1 ]
Lawrence, Christopher [1 ]
机构：
[1] South Tees Hosp NHS Fdn Trust, Middlesbrough, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P127
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana
    Smith, Tyler
    Samandari, Taraz
    Abimbola, Taiwo
    Marston, Barbara
    Sangrujee, Nalinee
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (03) : E84 - E93
  • [42] Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy
    Javier Blasco, Antonio
    Ramon Arribas, Jose
    Clotet, Bonaventura
    Domingo, Pere
    Gonzalez-Garcia, Juan
    Carlos Lopez-Bernaldo, Juan
    Llibre, Josep M.
    Lozano, Fernando
    Podzamczer, Daniel
    Miguel Santamaria, Juan
    Tuset, Montserrat
    Zamora, Laura
    Lazaro, Pablo
    Gatell, Josep M.
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (10): : 721 - 730
  • [43] Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy
    Burgos, Angel
    de Alvaro, Cristina
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (03): : 167 - 168
  • [44] Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness
    Kimmel, April D.
    Weinstein, Milton C.
    Anglaret, Xavier
    Goldie, Sue J.
    Losina, Elena
    Yazdanpanah, Yazdan
    Messou, Eugene
    Cotich, Kara L.
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (03) : 258 - 268
  • [45] A COST-EFFECTIVENESS EVALUATION FOR A NEW THERAPY IN HIV TREATMENT
    Malhan, S.
    Kockaya, G.
    Zengin, Elbir T.
    Dalgic, C.
    Yenilmez, F. B.
    Cerci, P.
    Oksuz, E.
    Tayfun, K.
    Unal, S.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A677 - A677
  • [46] Cost-effectiveness of current antiretroviral regimes
    Anis, AH
    Hogg, RS
    Wang, X
    Yip, B
    Guh, D
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    [J]. AIDS, 1998, 12 : S15 - S15
  • [47] The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy
    Ross, Eric L.
    Weinstein, Milton C.
    Schackman, Bruce R.
    Sax, Paul E.
    Paltiel, A. David
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    Losina, Elena
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (07) : 1102 - 1110
  • [48] Cost-Effectiveness of Tenofovir as First-Line Antiretroviral Therapy in India
    Bender, Melissa A.
    Kumarasamy, Nagalingeswaran
    Mayer, Kenneth H.
    Wang, Bingxia
    Walensky, Rochelle P.
    Flanigan, Timothy
    Schackman, Bruce R.
    Scott, Callie A.
    Lu, Zhigang
    Freedberg, Kenneth A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) : 416 - 425
  • [49] Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia
    Long, Elisa F.
    Brandeau, Margaret L.
    Galvin, Cristina M.
    Vinichenko, Tatyana
    Tole, Swati P.
    Schwartz, Adam
    Sanders, Gillian D.
    Owens, Douglas K.
    [J]. AIDS, 2006, 20 (17) : 2207 - 2215
  • [50] Cost to achieve an undetectable viral load using recommended antiretroviral regimens
    Basu, Rituparna P.
    Grimes, Richard M.
    Helmy, Amgad F.
    [J]. HIV CLINICAL TRIALS, 2006, 7 (06): : 309 - 318
12345